Tilray Confirms No Current Impact of Tariffs Generated Net Revenue of $186 Million in the Third Quarter, $193 Million in Constant Currency; Strategic Initiatives and SKU Rationalization Impacted ...

Carpenter Technology Corporation (NYSE: CRS) has announced plans to hold a conference call and webcast to discuss its ...

Good morning and welcome to the AngioDynamics fiscal year 20,253 quarter earnings call. (Operator Instructions) As a reminder, this conference call is being recorded. The news released detailing ...

Cintas delivered impressive fiscal 2025 third-quarter results with earnings and revenue exceeding market expectations.

Conagra's report for the third quarter ended February 23, 2025, indicates several challenges facing the company: Net Sales: Decreased by 6.3% to $2.8 billion, driven largely by a 5.2% decrease in ...

– Completed enrollment and dosing in a Phase 1a clinical trial in 72 healthy volunteers to assess safety and pharmacokinetic (PK) properties of SAT-3247 – Presented initial Phase 1a data at ...

Total 2024 revenue saw a modest increase as the Company’s capacity to meet demand in the Military and Public Safety sectors did not start to come on stream until late Q3. Key Financial Highlights ...

Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities into 2027Strengthened cash position expected to support ...

In December 2024, Elicio announced the completion of enrollment of the randomized Phase 2 AMPLIFY-7P clinical trial ( ...